Dr. Morris on how PSMA-PET imaging has “exploded” in the past year


“As the PSMA-PET market for access has grown, the coverage has actually been better than we anticipated when it first launched,” says David Morris, MD.

David Morris, MD, Urology Associates, Nashville, TN, discusses how PSMA-PET imaging is revolutionizing prostate cancer care. “We all recognize it’s better than conventional imaging in terms of finding metastatic lesions and with that, it enables us to grow our potential patient based for targeted therapies.” says Morris.

Related Videos
Man talking with doctor | Image Credit: © Khunatorn - stock.adobe.com
Dr. Daniel Spratt in an interview with Urology Times
Dr. Benjamin Lowentritt in an interview with Urology Times
Phillip H. Kuo, MD, PhD, FACR, answers a question during a Zoom video interview
blurred image of a clinic hallway
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Man talking with doctor | Image Credit: © Chinnapong - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.